Your browser doesn't support javascript.
loading
Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
Daenthanasanmak, Anusara; Iamsawat, Supinya; Chakraborty, Paramita; Nguyen, Hung D; Bastian, David; Liu, Chen; Mehrotra, Shikhar; Yu, Xue-Zhong.
Affiliation
  • Daenthanasanmak A; Department of Microbiology and Immunology and.
  • Iamsawat S; Department of Microbiology and Immunology and.
  • Chakraborty P; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
  • Nguyen HD; Department of Microbiology and Immunology and.
  • Bastian D; Department of Microbiology and Immunology and.
  • Liu C; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; and.
  • Mehrotra S; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
  • Yu XZ; Department of Microbiology and Immunology and.
Blood ; 133(3): 266-279, 2019 01 17.
Article in En | MEDLINE | ID: mdl-30514750
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Lymphocyte Activation / T-Lymphocytes, Regulatory / Graft vs Leukemia Effect / Sirtuin 1 / Graft vs Host Disease Type of study: Prognostic_studies Limits: Animals Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Lymphocyte Activation / T-Lymphocytes, Regulatory / Graft vs Leukemia Effect / Sirtuin 1 / Graft vs Host Disease Type of study: Prognostic_studies Limits: Animals Language: En Year: 2019 Type: Article